Denali Therapeutics Inc.DNLINASDAQ
LOADING
|||
Net Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-422.77M
↓ 175% below average
Average (9y)
$-153.89M
Historical baseline
Range
High:$71.14M
Low:$-422.77M
CAGR
+43.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-422.77M | -191.1% |
| 2023 | $-145.22M | +55.5% |
| 2022 | $-325.99M | -12.2% |
| 2021 | $-290.58M | -508.5% |
| 2020 | $71.14M | +136.0% |
| 2019 | $-197.61M | -445.3% |
| 2018 | $-36.24M | +58.9% |
| 2017 | $-88.19M | -1.8% |
| 2016 | $-86.65M | -416.2% |
| 2015 | $-16.79M | - |